EUVIMEDEUVIMED entdecken
Open Access

Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement

Francesca Castagnoli iD, Ricardo Donners, Nina Tunariu, Christina Messiou, Dow-Mu Koh

The British Journal of Radiology · 2023

DOI: 10.1259/bjr.20230240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Radiology, 2023. Verfasst von Francesca Castagnoli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Royal Marsden Hospital, Sutton, UK. Hauptthemen laut MEDLINE: Multiple Myeloma, Breast Neoplasms, Bone Neoplasms, Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare relative fat fraction (rFF) of active bone lesions from breast, prostate and myeloma malignancies and normal bone marrow; to assess its inter-reader agreement.

Methods

Patients with breast (n = 26), myeloma (n = 32) and prostate cancer (n = 52) were retrospectively evaluated. 110 baseline rFF maps from whole-body MRI were reviewed by two radiologists. Regions of interest for up to four focal active lesions in each patient were drawn on rFF maps, one each at the cervicothoracic spine, lumbosacral spine, pelvis and extremity. The mean and standard deviation of rFF were recorded. The rFF of normal marrow was measured in the pelvis for patients without diffuse bone disease (n = 88). We compared the rFF of malignant bone lesions and normal marrow using Mann–Whitney test. Interobserver agreement was assessed by interclass correlation coefficient.

Results

Malignant bone lesions showed significantly lower median rFF (13.87%) compared with normal marrow (89.76%) with little overlap (p < 0.0001). There was no significant difference in the median rFF of malignant lesions from breast (14.46%), myeloma (13.12%) and prostate cancer (13.67%) (p > 0.017, Bonferroni correction) and in the median rFF of bone disease according to their anatomical locations (p > 0.008, Bonferroni correction). There was excellent interobserver agreement (0.95).

Conclusion

The low rFF of active bone lesions in breast, prostate and myeloma malignancies provides high image contrast relative to normal marrow that may be used to detect bone metastases. Advances in knowledge This study shows the importance of rFF towards detecting bone metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBreast NeoplasmsBone NeoplasmsProstatic NeoplasmsMaleHumansBone MarrowObserver VariationRetrospective StudiesMagnetic Resonance Imaging

Autor:innen und Institutionen

  • Department of Radiology, Royal Marsden Hospital, Sutton, UK.
  • Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, UK.

ORCID-Profile: Francesca Castagnoli

Zitieren

APA

Castagnoli, F., Donners, R., Tunariu, N., Messiou, C., & Koh, D. M. (2023). Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement. The British Journal of Radiology. https://doi.org/10.1259/bjr.20230240

Vancouver

Castagnoli F, Donners R, Tunariu N, Messiou C, Koh DM. Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement. The British Journal of Radiology. 2023. doi:10.1259/bjr.20230240

BibTeX
@article{Castagnoli2023,
  author = {Castagnoli, Francesca and Donners, Ricardo and Tunariu, Nina and Messiou, Christina and Koh, Dow-Mu},
  title = {Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement},
  journal = {The British Journal of Radiology},
  year = {2023},
  doi = {10.1259/bjr.20230240}
}
Kostenlos starten →